先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2023, vol.15, no.1

题名作者出版年年卷期
A glyco-engineering approach for site-specific conjugation to Fab glycansMaria L. Jaramillo;Traian Sulea;Yves Durocher;Mauro Acchione;Melissa J. Schur;Anna Robotham;John F. Kelly;Marie-France Goneau;Alma Robert;Yuneivy Cepero-Donates;Michel Gilbert;20232023, vol.15, no.1
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-lifeEmma Davé;Oliver Durrant;Neha Dhami;Joanne Compson;Janice Broadbridge;Sophie Archer;Asher Maroof;Kevin Whale;Karelle Menochet;Pierre Bonnaillie;Emily Barry;Gavin Wild;Claude Peerboom;Pallavi Bhatta;Mark Ellis;Matthew Hinchliffe;David P. Humphreys;Sam P. Heywood;20232023, vol.15, no.1
Challenges in antibody structure predictionMonica L. Fernández-Quintero;Janik Kokot;Franz Waibl;Anna-Lena M. Fischer;Patrick K. Quoika;Charlotte M. Deane;Klaus R. Liedl;20232023, vol.15, no.1
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang;Jason Gorman;Young D. Kwon;Amarendra Pegu;Cara W. Chao;Tracy Liu;Mangaiarkarasi Asokan;Michael F. Bender;Tatsiana Bylund;Leland Damron;Deepika Gollapudi;Paula Lei;Yile Li;Cuiping Liu;Mark K. Louder;Krisha McKee;Adam S. Olia;Reda Rawi;Arne Schön;Shuishu Wang;Eun Sung Yang;Yongping Yang;Kevin Carlton;Nicole A. Doria-Rose;Lawrence Shapiro;Michael S. Seaman;John R. Mascola;Peter D. Kwong;20232023, vol.15, no.1
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus;Claudia Ferrara-Koller;Christian Klein;20232023, vol.15, no.1
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networksJonathan Schmitt;Abbas Razvi;Christoph Grapentin;20232023, vol.15, no.1
Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAbTsega L. Solomon;Frank Delaglio;John P. Giddens;John P. Marino;Yihua Bruce Yu;Marc B. Taraban;Robert G. Brinson;20232023, vol.15, no.1
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure featuresAmeya Harmalkar;Roshan Rao;Yuxuan Richard Xie;Jonas Honer;Wibke Deisting;Jonas Anlahr;Anja Hoenig;Julia Czwikla;Eva Sienz-Widmann;Doris Rau;Austin J. Rice;Timothy P. Riley;Danqing Li;Hannah B. Catterall;Christine E. Tinberg;Jeffrey J. Gray;Kathy Y. Wei;20232023, vol.15, no.1
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reactionFabian Bickel;François Griaud;Wolfram Kern;Frieder Kroener;Manuela Gritsch;Jérôme Dayer;Samuel Barteau;Blandine Denefeld;Chi-Ya Kao-Scharf;Manuel Lang;Izabela Slupska-Muanza;Carla Schmidt;Matthias Berg;Jürgen Sigg;Lina Boado;Dirk Chelius;20232023, vol.15, no.1
Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case studyDmitry Shchelokov;Oleg Demin Jr;20232023, vol.15, no.1
123